D
45
2
EMN
58
3
VZ
47
2
CNX
57
-2
GOOG
51
9
EMR
57
-2
L
73
4
AKAM
45
-16
DAL
54
3
DG
65
2
EBAY
53
5
T
50
2
NWL
64
3
KHC
18
7
HRL
30
4
BRK.B
47
7
TSCO
43
4
LEN
28
2
AAL
12
7
HCA
75
2
D
45
2
EMN
58
3
VZ
47
2
CNX
57
-2
GOOG
51
9
EMR
57
-2
L
73
4
AKAM
45
-16
DAL
54
3
DG
65
2
EBAY
53
5
T
50
2
NWL
64
3
KHC
18
7
HRL
30
4
BRK.B
47
7
TSCO
43
4
LEN
28
2
AAL
12
7
HCA
75
2
Financhill
Back

Spyre Therapeutics, Inc. 10K Form

Buy
72

SYRE
Spyre Therapeutics, Inc.

Last Price:
$43.26
Seasonality Move:
-1.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SYRE News And Ratings

See the #1 stock for the next 7 days that we like better than SYRE

SYRE Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-44.6M
Price / Cash Flow: 0
Annual Sales: $7.15
Price / Book: 5.99

Profitability

EPS (TTM): -2.07800
Net Income (TTM): $-135.8M
Gross Margin: $0
Return on Equity: -25.86%
Return on Assets: -22.64%

Spyre Therapeutics, Inc. Earnings Forecast

Key Spyre Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 12 years have been positive in 7 years.

Spyre Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SYRE
Website: spyre.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 13.25
Quick Ratio: 12.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SYRE Technical Analysis vs Fundamental Analysis

Buy
72
Spyre Therapeutics, Inc. (SYRE) is a Buy

Is Spyre Therapeutics, Inc. a Buy or a Sell?